In the early stages of disease, pancreatic β-cells retain the ability to secrete insulin but the patient develops insulin resistance, resulting in the compensatory secretion of more insulin from pancreatic β-cells to maintain normal blood glucose levels. This evidence concerns the gene INS and Insulin resistance.